INVO Bioscience, Inc., a commercial-stage fertility company, provides assisted reproductive technology solutions worldwide. Its flagship product is the INVOcell, a medical device that allows fertilization and early embryo development to take place in vivo within the woman's body. INVO Bioscience, Inc. was founded in 2007 and is based in Sarasota, Florida.
Stock data | 2024 | Change |
---|---|---|
Price | $0.686 | N/A |
Market Cap | $1.71M | N/A |
Shares Outstanding | 2.49M | N/A |
Employees | 15.00 | N/A |